Safe use of proton pump inhibitors in patients with cirrhosis.

about

Safe use of proton pump inhibitors in patients with cirrhosis.

Item

http://www.wikidata.org/entity/Q55718075

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Safe use of proton pump inhibitors in patients with cirrhosis.

@en

Safe use of proton pump inhibitors in patients with cirrhosis.

@nl

type

Item

label

Safe use of proton pump inhibitors in patients with cirrhosis.

@en

Safe use of proton pump inhibitors in patients with cirrhosis.

@nl

prefLabel

Safe use of proton pump inhibitors in patients with cirrhosis.

@en

Safe use of proton pump inhibitors in patients with cirrhosis.

@nl

P1476

Safe use of proton pump inhibitors in patients with cirrhosis.

@en

P2093

Margje H Monster-Simons

http://www.w3.org/2001/XMLSchema#string

Margriet Bouma

http://www.w3.org/2001/XMLSchema#string

Nicole G M Hunfeld

http://www.w3.org/2001/XMLSchema#string

S Froukje Harkes-Idzinga

http://www.w3.org/2001/XMLSchema#string

Sandra A W van Putten

http://www.w3.org/2001/XMLSchema#string

P2860

Overprescribing proton pump inhibitors

Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis

Dose adjustment in patients with liver disease

Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data.

Effects of liver disease on pharmacokinetics. An update.

Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites

Transection of the oesophagus for bleeding oesophageal varices.

Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.

Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.

Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.

P304

1806-1820

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13615

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29688583

http://www.w3.org/2001/XMLSchema#string

P932

6046475

http://www.w3.org/2001/XMLSchema#string